| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T75 |
1-2 |
IN |
denotes |
• |
| T76 |
4-15 |
NNP |
denotes |
Tocilizumab |
| T77 |
15-16 |
-COMMA- |
denotes |
, |
| T78 |
17-19 |
DT |
denotes |
an |
| T79 |
20-28 |
NN |
denotes |
anti-IL6 |
| T80 |
28-29 |
-COMMA- |
denotes |
, |
| T81 |
30-33 |
MD |
denotes |
can |
| T82 |
34-40 |
VB |
denotes |
confer |
| T83 |
41-48 |
NN |
denotes |
benefit |
| T84 |
49-51 |
IN |
denotes |
in |
| T85 |
52-60 |
NNS |
denotes |
patients |
| T86 |
61-65 |
IN |
denotes |
with |
| T87 |
66-74 |
NN |
denotes |
COVID-19 |
| T88 |
75-78 |
CC |
denotes |
and |
| T89 |
79-83 |
JJ |
denotes |
high |
| T90 |
84-87 |
NN |
denotes |
IL6 |
| T91 |
90-98 |
NN |
denotes |
Abstract |
| T92 |
99-102 |
DT |
denotes |
The |
| T93 |
103-108 |
JJ |
denotes |
novel |
| T94 |
109-120 |
NN |
denotes |
coronavirus |
| T95 |
120-121 |
-COMMA- |
denotes |
, |
| T96 |
122-131 |
NN |
denotes |
SARS-CoV2 |
| T97 |
131-132 |
-COMMA- |
denotes |
, |
| R69 |
T82 |
T75 |
arg1Of |
confer,• |
| R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
| R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
| R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
| R73 |
T82 |
T80 |
arg1Of |
confer,"," |
| R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |
| R75 |
T82 |
T81 |
arg2Of |
confer,can |
| R76 |
T76 |
T82 |
arg1Of |
Tocilizumab,confer |
| R77 |
T83 |
T82 |
arg2Of |
benefit,confer |
| R78 |
T82 |
T84 |
arg1Of |
confer,in |
| R79 |
T85 |
T84 |
arg2Of |
patients,in |
| R80 |
T85 |
T86 |
arg1Of |
patients,with |
| R81 |
T88 |
T86 |
arg2Of |
and,with |
| R82 |
T87 |
T88 |
arg1Of |
COVID-19,and |
| R83 |
T90 |
T88 |
arg2Of |
IL6,and |
| R84 |
T90 |
T89 |
arg1Of |
IL6,high |
| R85 |
T94 |
T92 |
arg1Of |
coronavirus,The |
| R86 |
T94 |
T93 |
arg1Of |
coronavirus,novel |
| R87 |
T94 |
T95 |
arg1Of |
coronavirus,"," |
| R88 |
T96 |
T95 |
arg2Of |
SARS-CoV2,"," |
